Advanced search

Antibodies to E1 and E2 in patients infected with HCV1b : evolution of antibody levels after interferon therapy

(1997) HEPATOLOGY. 26(4, suppl.). p.338-338
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Depraetere, Stany, E Van Kerschaver, André Elewaut, J Brouwer, B Niesters, S Schalm, G Maertens, and Geert Leroux-Roels. 1997. “Antibodies to E1 and E2 in Patients Infected with HCV1b : Evolution of Antibody Levels After Interferon Therapy.” In Hepatology, 26:338–338.
APA
Depraetere, S., Van Kerschaver, E., Elewaut, A., Brouwer, J., Niesters, B., Schalm, S., Maertens, G., et al. (1997). Antibodies to E1 and E2 in patients infected with HCV1b : evolution of antibody levels after interferon therapy. HEPATOLOGY (Vol. 26, pp. 338–338).
Vancouver
1.
Depraetere S, Van Kerschaver E, Elewaut A, Brouwer J, Niesters B, Schalm S, et al. Antibodies to E1 and E2 in patients infected with HCV1b : evolution of antibody levels after interferon therapy. HEPATOLOGY. 1997. p. 338–338.
MLA
Depraetere, Stany, E Van Kerschaver, André Elewaut, et al. “Antibodies to E1 and E2 in Patients Infected with HCV1b : Evolution of Antibody Levels After Interferon Therapy.” Hepatology. Vol. 26. 1997. 338–338. Print.
@inproceedings{271339,
  author       = {Depraetere, Stany and Van Kerschaver, E and Elewaut, Andr{\'e} and Brouwer, J and Niesters, B and Schalm, S and Maertens, G and Leroux-Roels, Geert},
  booktitle    = {HEPATOLOGY},
  issn         = {0270-9139},
  language     = {eng},
  number       = {4, suppl.},
  pages        = {338--338},
  title        = {Antibodies to E1 and E2 in patients infected with HCV1b : evolution of antibody levels after interferon therapy},
  volume       = {26},
  year         = {1997},
}